Key result
Labetalol rapidly lowers blood pressure without tolerance, with twice-daily dosing minimizing postural hypotension.
Answers are grounded in this paper and cite their sources.
1 Labetalol is an effective agent in essential hypertension as documented in open studies and controlled studies in which its efficacy has been compared with both placebo and a variety of other anti-hypertensive drugs. 2 Labetalol given by mouth lowers blood pressure rapidly. There is no evidence of tolerance to its anti-hypertensive action. 3 Adverse effects include excessive hypotension, but only when the drug is given in large doses. Epigastric discomfort and scalp tingling have been documented especially after intravenous administration. 4 From a pharmacokinetic and pharmacodynamic point of view, labetalol can be given once daily, but postural hypotension after large (greater than 1 g) single doses may limit the usefulness of once daily regimes. Twice daily administration appears an acceptable compromise.
No takes yet. Share an insight, caveat, or question.
Breckenridge et al. (1982) conducted a review in Essential hypertension. Labetalol was evaluated. Labetalol is an effective anti-hypertensive agent that rapidly lowers blood pressure without tolerance, best administered twice daily to avoid postural hypotension seen with large single doses.
Synapse has enriched 10 related papers. Consider them for comparative context: